Please try another search
Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Hans Jorg Meisel | - | 2021 | Member of Scientific Advisory Board |
Erik Kinnmann | 65 | 2020 | Director |
Gunnar Fernstromas | 73 | 2021 | Independent Director |
Gudrun Anstren | 68 | 2021 | Independent Director |
Daisuke Sakai | - | 2023 | Member of Scientific Advisory Board |
Jane Buus Laursen | 48 | 2018 | Independent Director |
Björn Strömqvist | - | - | Member of Scientific Advisory Board |
Ulf Bjorklund | 67 | 2021 | Chairman of the Board |
Douglas P. Beall | - | 2021 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review